This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (88)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Macular Degeneration  • Alert me on articles by topic

Follow-up at 6 Years in the Rotterdam Study

Redmer van Leeuwen, MD; Caroline C. W. Klaver, MD, PhD; Johannes R. Vingerling, MD, PhD; Albert Hofman, MD, PhD; Paulus T. V. M. de Jong, MD, PhD, FRCOphth

Arch Ophthalmol. 2003;121:519-526.

ABSTRACT
Objectives  To evaluate the natural course of age-related maculopathy (ARM) and to assess the incidence and absolute risk of its final stage, age-related macular degeneration (AMD).

Methods  In a population-based prospective cohort study of 6418 persons 55 years and older, we studied the incidence and natural course of ARM. Subjects underwent identical examinations, including stereoscopic fundus photography, at baseline and at 2.0 and 6 years' follow-up. Age-related maculopathy was graded according to the International Classification and Grading System for ARM and AMD, and stratified into 5 exclusive stages. Incidence was expressed in rates and 5-year absolute risks.

Results  At follow-up, 47 new cases of AMD were identified, with a ratio of neovascular-atrophic AMD of 1.4:1. The 5-year risk of AMD increased with more severe stages to 28.0% for subjects 55 years and older with indistinct drusen and pigmentary irregularities (stage 3). Age, but not sex, independently increased this risk to a maximum of 42.0% for subjects with stage 3 ARM who were 80 years and older. Individual ARM fundus signs that predicted best the development of AMD were 10 or more large drusen (125 µm) and 10% or more of the grid area covered by drusen. Subjects who developed atrophic AMD showed no significant (P = .25) differences in baseline fundus signs and natural course compared with subjects who developed neovascular AMD.

Conclusions  We provided the absolute risk of AMD as a function of age and early ARM fundus signs, and showed that both are prominent independent risk factors. The progression of ARM stages follows, after the appearance of the first soft drusen, a distinct course at a gradual pace that accelerates with increasing age.

From the Departments of Epidemiology & Biostatistics (Drs van Leeuwen, Klaver, Vingerling, Hofman, and de Jong) and Ophthalmology (Drs Klaver and Vingerling), Erasmus Medical Center, Rotterdam, the Netherlands; and the Netherlands Ophthalmic Research Institute, Royal Netherlands Academy of Arts and Sciences, and the Department of Ophthalmology, Academic Medical Center, Amsterdam (Dr de Jong), the Netherlands. The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration
Augood et al.
Am. J. Clin. Nutr. 2008;88:398-406.
ABSTRACT | FULL TEXT  

Interleukin Gene Polymorphisms in Age-Related Macular Degeneration
Tsai et al.
IOVS 2008;49:693-698.
ABSTRACT | FULL TEXT  

Comprehensive Analysis of the Candidate Genes CCL2, CCR2, and TLR4 in Age-Related Macular Degeneration
Despriet et al.
IOVS 2008;49:364-371.
ABSTRACT | FULL TEXT  

C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Boekhoorn et al.
Arch Ophthalmol 2007;125:1396-1401.
ABSTRACT | FULL TEXT  

Ethnic Differences in Macular Pigment Density and Distribution
Wolf-Schnurrbusch et al.
IOVS 2007;48:3783-3787.
ABSTRACT | FULL TEXT  

Preventing Depression in Age-Related Macular Degeneration
Rovner et al.
Arch Gen Psychiatry 2007;64:886-892.
ABSTRACT | FULL TEXT  

Complement Factor H Polymorphism, Inflammatory Mediators, and Retinal Vessel Diameters: The Rotterdam Study
de Jong et al.
IOVS 2007;48:3014-3018.
ABSTRACT | FULL TEXT  

Estrogen Receptor {alpha} Gene Polymorphisms Associated with Incident Aging Macula Disorder
Boekhoorn et al.
IOVS 2007;48:1012-1017.
ABSTRACT | FULL TEXT  

Retinal Pigment Epithelium Rescues Vascular Endothelium from Retinoic Acid-Induced Apoptosis
Tezel et al.
IOVS 2006;47:5075-5087.
ABSTRACT | FULL TEXT  

Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.
Korobelnik et al.
IOVS 2006;47:4270-4276.
ABSTRACT | FULL TEXT  

Severity Staging by Early Features of Age-Related Maculopathy Exhibits Weak Relationships with Functional Deficits on SWS Grating Acuity.
Beirne et al.
IOVS 2006;47:4624-4631.
ABSTRACT | FULL TEXT  

Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
Despriet et al.
JAMA 2006;296:301-309.
ABSTRACT | FULL TEXT  

Plasma Lutein and Zeaxanthin and Other Carotenoids as Modifiable Risk Factors for Age-Related Maculopathy and Cataract: The POLA Study.
Delcourt et al.
IOVS 2006;47:2329-2335.
ABSTRACT | FULL TEXT  

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).
Augood et al.
Arch Ophthalmol 2006;124:529-535.
ABSTRACT | FULL TEXT  

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Presence of Age-Related Macular Degeneration in the Cardiovascular Health Study
McGwin et al.
Arch Ophthalmol 2006;124:33-37.
ABSTRACT | FULL TEXT  

Dietary Intake of Antioxidants and Risk of Age-Related Macular Degeneration
van Leeuwen et al.
JAMA 2005;294:3101-3107.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 17
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1484-1498.
ABSTRACT | FULL TEXT  

Inflammatory Markers in Age-Related Maculopathy: Cross-sectional Analysis From the Muenster Aging and Retina Study
Dasch et al.
Arch Ophthalmol 2005;123:1501-1506.
ABSTRACT | FULL TEXT  

A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1570-1574.
ABSTRACT | FULL TEXT  

Prevalence of Age-Related Macular Degeneration in a Population-Based Sample of Hispanic People in Arizona: Proyecto VER
Munoz et al.
Arch Ophthalmol 2005;123:1575-1580.
ABSTRACT | FULL TEXT  

Age-Related Eye Disease Study Severity Scale and Simplified Severity Scale for Age-Related Macular Degeneration
Mitchell and Foran
Arch Ophthalmol 2005;123:1598-1599.
FULL TEXT  

Serum Elastin-Derived Peptides in Age-Related Macular Degeneration
Sivaprasad et al.
IOVS 2005;46:3046-3051.
ABSTRACT | FULL TEXT  

Reduced Foveolar Choroidal Blood Flow in Eyes with Increasing AMD Severity
Grunwald et al.
IOVS 2005;46:1033-1038.
ABSTRACT | FULL TEXT  

Association of Drusen Deposition with Choroidal Intercapillary Pillars in the Aging Human Eye
Lengyel et al.
IOVS 2004;45:2886-2892.
ABSTRACT | FULL TEXT  

Are Retinal Arteriolar or Venular Diameters Associated with Markers for Cardiovascular Disorders? The Rotterdam Study
Ikram et al.
IOVS 2004;45:2129-2134.
ABSTRACT | FULL TEXT  

Prevalence of Age-Related Macular Degeneration in the United States
The Eye Diseases Prevalence Research Group
Arch Ophthalmol 2004;122:564-572.
ABSTRACT | FULL TEXT  

Blood Pressure, Atherosclerosis, and the Incidence of Age-Related Maculopathy: The Rotterdam Study
van Leeuwen et al.
IOVS 2003;44:3771-3777.
ABSTRACT | FULL TEXT  

Relationship between Refraction and Prevalent as well as Incident Age-Related Maculopathy: The Rotterdam Study
Ikram et al.
IOVS 2003;44:3778-3782.
ABSTRACT | FULL TEXT